Similar articles for PMID: 30878433

Year	Number of Results
1974	1
1984	1
1997	1
2004	1
2006	1
2007	1
2008	3
2009	3
2010	2
2011	8
2012	14
2013	11
2014	12
2015	9
2016	10
2017	14
2018	10
2019	7
2020	6
2021	2
2022	2
2024	0

1

Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging: Cases and Treatment Recommendations.

Derbas LA, Thomas GS, Medina CA, Abdel-Karim AA, Saeed IM, Bateman TM. Derbas LA, et al. JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1288-1290. doi: 10.1016/j.jcmg.2019.01.017. Epub 2019 Mar 13. JACC Cardiovasc Imaging. 2019. PMID: 30878433 Free article. No abstract available.

2

Serious complications associated with regadenoson administration for myocardial perfusion imaging.

Kitt T, Jiang J. Kitt T, et al. J Nucl Cardiol. 2015 Apr;22(2):395. doi: 10.1007/s12350-014-0048-5. Epub 2014 Dec 30. J Nucl Cardiol. 2015. PMID: 25548120 Free PMC article. No abstract available.

3

[Asystole after regadenoson administration to perform a myocardial perfusion imaging test].

Briegas Morera D, Martín Clavo S, Estepa Alonso MJ, Rangel Mayoral JF. Briegas Morera D, et al. Farm Hosp. 2017 Jul 1;41(4):563-564. doi: 10.7399/fh.2017.41.4.10764. Farm Hosp. 2017. PMID: 28683710 Spanish. No abstract available.

4

Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.

Hage FG, Iskandrian AE. Hage FG, et al. J Nucl Cardiol. 2014 Oct;21(5):877-9. doi: 10.1007/s12350-014-9985-2. J Nucl Cardiol. 2014. PMID: 25156654 No abstract available.

5

Regadenoson for myocardial perfusion imaging: Is it safe?

Hage FG. Hage FG. J Nucl Cardiol. 2014 Oct;21(5):871-6. doi: 10.1007/s12350-014-9922-4. Epub 2014 Jun 19. J Nucl Cardiol. 2014. PMID: 24939324 No abstract available.

6

Asystole following regadenoson infusion in stable outpatients.

Rosenblatt J, Mooney D, Dunn T, Cohen M. Rosenblatt J, et al. J Nucl Cardiol. 2014 Oct;21(5):862-8. doi: 10.1007/s12350-014-9898-0. Epub 2014 May 31. J Nucl Cardiol. 2014. PMID: 24879452

7

Pituitary apoplexy after regadenoson myocardial perfusion scan.

Shetty S, Gnanaraj J, Jayamani Roshan S, El Accaoui R. Shetty S, et al. J Nucl Cardiol. 2020 Feb;27(1):336-339. doi: 10.1007/s12350-018-1428-z. Epub 2018 Aug 30. J Nucl Cardiol. 2020. PMID: 30168027 No abstract available.

8

Asystole following Regadenoson administration: Review of literature, risk factors and management.

Asif T, Lee Chuy K, Malhotra S. Asif T, et al. J Nucl Cardiol. 2021 Oct;28(5):2046-2055. doi: 10.1007/s12350-020-02136-x. Epub 2020 May 27. J Nucl Cardiol. 2021. PMID: 32462632 Review.

9

Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.

Amer KA, Hurren JR, Edwin SB, Cohen G. Amer KA, et al. Pharmacotherapy. 2017 Jun;37(6):657-661. doi: 10.1002/phar.1940. Epub 2017 May 26. Pharmacotherapy. 2017. PMID: 28475259

10

Coronary vasospasm during a regadenoson stress test.

Bagley SJ, Lilly SM, Litwack AJ. Bagley SJ, et al. Cardiol J. 2012;19(1):92-4. doi: 10.5603/cj.2012.0016. Cardiol J. 2012. PMID: 22298176 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year